TiE-Boston Lifesciences Forum and TiE Women’s Initiative (TiE-Win)

are delighted to announce a discussion on:

Lifesciences, Outsourcing, and Growth Opportunities in India

The U.S. biopharma industry is facing several emerging challenges, triggering the need for a new business model for the industry. As R&D costs escalate and R&D productivity stagnates, pharma companies face increasing pressures to outsource several tasks and R&D processes. At the same time, India’s emerging lifesciences industry has demonstrated nascent capabilities in both discovery and clinical development, and promises to provide a complementary set of capabilities to U.S. and European biopharma companies. With the enforcement of the WTO TRIPS agreement in January 2005, intellectual property (IP) issues are expected to become less of a hurdle, potentially triggering a dramatic shift in the global biopharma industry. The keynote speaker and panelists will discuss these issues and present their opinions.

Panelists:

Kelly Blackburn, Millennium Pharmaceuticals

Dr. Nick Terrett, Pfizer Inc.

Dr. Govinda Rao, Vertex Pharmaceuticals

John Serio, Attorney, Brown Rudnick Berlack Israels

Dr. Anil Khurana, Access International Partners, LLC

Dr. Jugnu Jain, Vertex Pharmaceuticals

When:

Thursday, February 17, 2005

6:30 PM – 9:30 PM

Where:

Millennium Pharmaceuticals Main Lobby

35 Landsdowne Street, Cambridge, MA 02139

(For directions and parking for 35 Landsdowne Street, please see http://www.mlnm.com/contactus.asp)

|